Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.

NCT07195864 · clinicaltrials.gov ↗
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

SIFI SpA